I don't know of any specific circumstances where that kind of procedure is in place. I believe that in Canada, industry has dealt with this issue fairly effectively. Industries such as the soybean industry, which has both GM and non-GM product, have been able to look at markets and determine that there are certain markets that require only non-GM product. They have been able to set up a system to IP that product and keep it separate and segregated so that they can serve that market at the same time as they are growing GM varieties. Canada and industry and regulators have been able to deal with this effectively.
We are concerned, from the point of view of trade externally, about the criteria used for this kind of analysis. As I said in my opening presentation, we're exporting about 90% of the product we grow. We're contributing $14 billion to the Canadian economy with the product we grow. So we need predictable access to those markets. The best way to do that, in our view, is to have it based on principles of health and safety and the protection of the environment. Going beyond that into other criteria allows countries we might be exporting to to put different criteria into their evaluation processes that aren't clear, that aren't predictable, and that make it very difficult for us to access those markets.
That's the answer I'd provide to this.